Résultats de recherche - Portail des modèles médicaux de données (portail MDM)

Southwest Oncology Group Registration Form (S0421) NCT00134056

- 20/09/2021 - 1 Formulaire, 3 Groupes Item, 40 Eléments de données, 1 Langue

Groupes Item: Header, Patient demographics, Miscellaneous Patient Information

Southwest Oncology Group Registration Form (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A11DF-588A-2157-E034-0003BA3F9857

Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056

- 20/09/2021 - 1 Formulaire, 3 Groupes Item, 53 Eléments de données, 1 Langue

Groupes Item: Header, Randomization questions, Patient status assessment

Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159B9D6-FD84-2C7B-E034-0003BA3F9857

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases - Radium 223 Dichloride (Alpharadin) - Screening Visit

- 13/02/2017 - 1 Formulaire, 9 Groupes Item, 89 Eléments de données, 1 Langue

Groupes Item: Demography, Vital Signs, Prostate Cancer Classification, BPI-SF, ECOG Performance Status, Prior radiotherapy, Prior diagnostic and therapeutic procedures for prostate cancer, Hematology (with DBC), General chemistry - Serum

This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form

- 28/07/2015 - 1 Formulaire, 5 Groupes Item, 26 Eléments de données, 1 Langue

Groupes Item: Header, STATUS, TREATMENT, ARM 1 + ARM 2, COMMENTS

SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A78DC-93A4-2746-E034-0003BA3F9857

Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056

- 27/06/2015 - 1 Formulaire, 2 Groupes Item, 18 Eléments de données, 1 Langue

Groupes Item: SWOG clinical trial administrative data, Patient demographics

Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F977EF7-B9B7-51FB-E044-0003BA3F9857

CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001

- 21/06/2015 - 1 Formulaire, 5 Groupes Item, 23 Eléments de données, 1 Langue

Groupes Item: Header, Patient demographics, Target Lesion(s) Baseline Evaluation, Non-target lesion(s) Baseline Evaluation, CCRR MODULE

CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001 Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4605F45-F7E1-0518-E034-0003BA12F5E7

SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056

- 12/06/2015 - 1 Formulaire, 3 Groupes Item, 17 Eléments de données, 1 Langue

Groupes Item: Header, Patient Instructions, Patient medical history

SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D64D5-FB3B-3049-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form - 2464820v1.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 20 Eléments de données, 1 Langue

Groupes Item: Header, ADVERSE EVENTS, Comments

SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D4F4F-BA23-2F60-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization - 2305232v3.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 20 Eléments de données, 1 Langue

Groupes Item: Header, ADVERSE EVENTS, Comments

SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B0C64-8BEB-3314-E034-0003BA3F9857

Prostate Cancer NCT00079001 On-Study - CALGB 90202: Skeletal Survey Form - 2083769v3.0 - CALGB 90202: Skeletal Survey Form

- 09/01/2015 - 1 Formulaire, 1 Groupe Item, 22 Eléments de données, 1 Langue

Groupe Item: CCRR MODULE

CALGB 90202: Skeletal Survey Form Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7BE7E12-C8DF-7003-E034-0003BA12F5E7

Metastatic Cancer NCT00134056 Response - Southwest Oncology Group - Bisphosphonate Usage Form - 2759910v1.0 - Southwest Oncology Group - Bisphosphonate Usage Form

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 19 Eléments de données, 1 Langue

Groupes Item: Header, Header, Comments

Southwest Oncology Group - Bisphosphonate Usage Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4FD609AB-09CA-1C94-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Response - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM - 2304629v3.0 - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 12 Eléments de données, 1 Langue

Groupes Item: Header, PSA MEASUREMENTS, Comments

SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159832A-A1FF-27F6-E034-0003BA3F9857

Mots-clés

Table des matières

Modèles de données sélectionnés